Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lindner

Showing results (651-660 of 708) with videos related to

Pageof 71
Sort By:
Cancer Research|September 7, 2012
Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumorsAshley A Manzoor, Lars H Lindner, Chelsea D Landon, et al.
Clinical & Experimental Metastasis|February 29, 2024
Differentiation of benign and metastatic lymph nodes in soft tissue sarcomaAnton Burkhard-Meier, Vindi Jurinovic, Luc M Berclaz, et al.
The Review of Scientific Instruments|January 3, 2019
Time-of-flight spectrometry of ultra-short, polyenergetic proton bunchesMatthias Würl, Franz S Englbrecht, Sebastian Lehrack, et al.
Gynecologic Oncology|May 22, 2016
Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapyI Ray-Coquard, E Rizzo, J Y Blay, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2017
Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trialPatrick Schöffski, Agnieszka Wozniak, Bernard Escudier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2020
Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup StudyViktor Grünwald, Annika Karch, Markus Schuler, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 19, 2023
Hyperthermia in the treatment of high-risk soft tissue sarcomas: a systematic reviewParaskevi Danai Veltsista, Eva Oberacker, Adela Ademaj, et al.
Nature Genetics|July 16, 2002
Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger-Huët anomaly)Katrin Hoffmann, Christine K Dreger, Ada L Olins, et al.
Annals of Emergency Medicine|April 6, 2001
Use of pressors in the treatment of cardiac arrestC F Babbs, R A Berg, F Kette, et al.
International Journal of Cancer|February 1, 2018
Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)Lars H Lindner, Saskia Litière, Stefan Sleijfer, et al.
Pageof 71

Showing results (651-660 of 708) with videos related to

Sort By:
Pageof 71
Cancer Research|September 7, 2012
Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumorsAshley A Manzoor, Lars H Lindner, Chelsea D Landon, et al.
Clinical & Experimental Metastasis|February 29, 2024
Differentiation of benign and metastatic lymph nodes in soft tissue sarcomaAnton Burkhard-Meier, Vindi Jurinovic, Luc M Berclaz, et al.
The Review of Scientific Instruments|January 3, 2019
Time-of-flight spectrometry of ultra-short, polyenergetic proton bunchesMatthias Würl, Franz S Englbrecht, Sebastian Lehrack, et al.
Gynecologic Oncology|May 22, 2016
Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapyI Ray-Coquard, E Rizzo, J Y Blay, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2017
Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trialPatrick Schöffski, Agnieszka Wozniak, Bernard Escudier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2020
Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup StudyViktor Grünwald, Annika Karch, Markus Schuler, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 19, 2023
Hyperthermia in the treatment of high-risk soft tissue sarcomas: a systematic reviewParaskevi Danai Veltsista, Eva Oberacker, Adela Ademaj, et al.
Nature Genetics|July 16, 2002
Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger-Huët anomaly)Katrin Hoffmann, Christine K Dreger, Ada L Olins, et al.
Annals of Emergency Medicine|April 6, 2001
Use of pressors in the treatment of cardiac arrestC F Babbs, R A Berg, F Kette, et al.
International Journal of Cancer|February 1, 2018
Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)Lars H Lindner, Saskia Litière, Stefan Sleijfer, et al.
Pageof 71